{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:55:06Z","timestamp":1770814506415,"version":"3.50.1"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.7314","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T17:09:06Z","timestamp":1479143346000},"page":"3285-3289","source":"Crossref","is-referenced-by-count":15,"title":["Edoxaban Was Effective for the Treatment of Deep Vein Thrombosis and Pulmonary Thromboembolism in a Cancer Patient with Antithrombin III Deficiency"],"prefix":"10.2169","volume":"55","author":[{"given":"Hiroaki","family":"Kawano","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Maemura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 151: 933-938, 1991.","DOI":"10.1001\/archinte.1991.00400050081016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125: 1-7, 1996.","DOI":"10.7326\/0003-4819-125-1-199607010-00001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thromb Haemost 101: 806-812, 2009.","DOI":"10.1160\/TH08-10-0672"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Posch F, K\u00f6nigsbr\u00fcgge O, Zielinski C, Pabinger I, Ay C. Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants. Thromb Res 136: 582-589, 2015.","DOI":"10.1016\/j.thromres.2015.07.011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hokusai-VTE Investigators, B\u00fcller HR, D\u00e9cousus H, Grosso MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369: 1406-1415, 2013.","DOI":"10.1056\/NEJMoa1306638"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakamura M, Wang YQ, Wang C, et al. Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial. J Thromb Haemost 13: 1606-1614, 2015.","DOI":"10.1111\/jth.13055"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fukuda T, Kamisato C, Honda Y, et al. Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin. Thromb Res 131: 540-546, 2013.","DOI":"10.1016\/j.thromres.2013.04.016"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Davis DA, Fugate SE. Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy. Pharmacotherapy 25: 442-447, 2005.","DOI":"10.1592\/phco.25.3.442.61598"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Helsby NA, Lo WY, Thompson P, Laking GR. Do 5-fluorouracil therapies alter CYP2C19 metaboliser status? Cancer Chemother Pharmacol 66: 405-407, 2010.","DOI":"10.1007\/s00280-010-1277-1"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/22\/55_55.7314\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T11:38:22Z","timestamp":1568547502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/22\/55_55.7314\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":9,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.7314","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}